» Articles » PMID: 26559530

Design and Investigation of PolyFermS In Vitro Continuous Fermentation Models Inoculated with Immobilized Fecal Microbiota Mimicking the Elderly Colon

Overview
Journal PLoS One
Date 2015 Nov 13
PMID 26559530
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro gut modeling is a useful approach to investigate some factors and mechanisms of the gut microbiota independent of the effects of the host. This study tested the use of immobilized fecal microbiota to develop different designs of continuous colonic fermentation models mimicking elderly gut fermentation. Model 1 was a three-stage fermentation mimicking the proximal, transverse and distal colon. Models 2 and 3 were based on the new PolyFermS platform composed of an inoculum reactor seeded with immobilized fecal microbiota and used to continuously inoculate with the same microbiota different second-stage reactors mounted in parallel. The main gut bacterial groups, microbial diversity and metabolite production were monitored in effluents of all reactors using quantitative PCR, 16S rRNA gene 454-pyrosequencing, and HPLC, respectively. In all models, a diverse microbiota resembling the one tested in donor's fecal sample was established. Metabolic stability in inoculum reactors seeded with immobilized fecal microbiota was shown for operation times of up to 80 days. A high microbial and metabolic reproducibility was demonstrated for downstream control and experimental reactors of a PolyFermS model. The PolyFermS models tested here are particularly suited to investigate the effects of environmental factors, such as diet and drugs, in a controlled setting with the same microbiota source.

Citing Articles

modeling of feline gut fermentation: a comprehensive analysis of fecal microbiota and metabolic activity.

Ren Q, Li Y, Duan M, Li J, Shi F, Zhou Y Front Microbiol. 2025; 16:1515865.

PMID: 39944651 PMC: 11813885. DOI: 10.3389/fmicb.2025.1515865.


Gut microbial dysbiosis associated to diarrheic irritable bowel syndrome can be efficiently simulated in the Mucosal ARtificial COLon (M-ARCOL).

Uriot O, Deschamps C, Scanzi J, Brun M, Kerckhove N, Duale C Bioengineered. 2025; 16(1):2458362.

PMID: 39902883 PMC: 11796540. DOI: 10.1080/21655979.2025.2458362.


Disclosing α-lactalbumin impact on the intestinal and vaginal microbiota of women suffering from polycystic ovary syndrome.

Alessandri G, Mancabelli L, Fontana F, Lepore E, Forte G, Burratti M Microb Biotechnol. 2024; 17(10):e14540.

PMID: 39364592 PMC: 11450379. DOI: 10.1111/1751-7915.14540.


Impact of cryoprotective agents on human gut microbes and in vitro stabilized artificial gut microbiota communities.

Alessandri G, Rizzo S, Mancabelli L, Fontana F, Longhi G, Turroni F Microb Biotechnol. 2024; 17(6):e14509.

PMID: 38878269 PMC: 11179620. DOI: 10.1111/1751-7915.14509.


New Horizons in Probiotics: Unraveling the Potential of Edible Microbial Polysaccharides through In Vitro Digestion Models.

Wang Y, Zhu S, Zhang T, Gao M, Zhan X Foods. 2024; 13(5).

PMID: 38472826 PMC: 10931329. DOI: 10.3390/foods13050713.


References
1.
Tiihonen K, Tynkkynen S, Ouwehand A, Ahlroos T, Rautonen N . The effect of ageing with and without non-steroidal anti-inflammatory drugs on gastrointestinal microbiology and immunology. Br J Nutr. 2008; 100(1):130-7. DOI: 10.1017/S000711450888871X. View

2.
Van den Abbeele P, Grootaert C, Marzorati M, Possemiers S, Verstraete W, Gerard P . Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX. Appl Environ Microbiol. 2010; 76(15):5237-46. PMC: 2916472. DOI: 10.1128/AEM.00759-10. View

3.
Evans J, Fleming K, Talley N, Schleck C, Zinsmeister A, Melton 3rd L . Relation of colonic transit to functional bowel disease in older people: a population-based study. J Am Geriatr Soc. 1998; 46(1):83-7. DOI: 10.1111/j.1532-5415.1998.tb01018.x. View

4.
Woodmansey E . Intestinal bacteria and ageing. J Appl Microbiol. 2007; 102(5):1178-86. DOI: 10.1111/j.1365-2672.2007.03400.x. View

5.
Baines S, Freeman J, Wilcox M . Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model. J Antimicrob Chemother. 2005; 55(6):974-82. DOI: 10.1093/jac/dki120. View